Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 4, Issue 1-2, Pages 31-35
http://dx.doi.org/10.1155/S1357714X00000062

Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas. The Experience of the EORTC Soft Tissue and Bone Sarcoma Group

1Centre for Bone and Soft Tissue Sarcomas, Aarhus University Hospital, Aarhus, Denmark
2Department of Oncology, Copenhagen University Hospital, Herlev, Denmark
3The Finsen Center, Rigshospitalet, Copenhagen, Denmark
4The Laboratory Center, Rigshospitalet, Copenhagen, Denmark
5EORTC Data Centre, Brussels, Belgium and Department of Medical Oncology, The Netherlands
6Rotterdam Cancer Institute (Daniel den Hoed Kliniek) and University Hospital, Rotterdam, The Netherlands

Copyright © 2000 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ole S. Nielsen, Per Dombernowsky, Henning Mouridsen, et al., “Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas. The Experience of the EORTC Soft Tissue and Bone Sarcoma Group,” Sarcoma, vol. 4, no. 1-2, pp. 31-35, 2000. https://doi.org/10.1155/S1357714X00000062.